Exosens publishes transcript of H1 2026 results presentation

• Exosens released the transcript of its H1 2026 results call attended by CEO Jérôme Cerisier, CFO Quynh-Boi Demey, IR head Laurent Sfaxi.
• H1 revenue EUR 253.1 million, up 15.3% year-on-year; adjusted EBITDA EUR 83.6 million, up 18.3%, margin 33%.
• 2026 guidance shifted toward the upper end: revenue EUR 520 million–EUR 540 million; adjusted EBITDA EUR 168 million–EUR 178 million.
• Image intensifier capacity expansion of about 40% by end-2027 vs 2024; Europe benefits expected in H2 2026, US deliveries in H1 2027.
• M&A pipeline described as seven to eight targets; scope broadened to deals with EUR 50 million–EUR 100 million sales, alongside smaller tech buys.

Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Exosens SA published the original content used to generate this news brief on August 03, 2026, and is solely responsible for the information contained therein.